检索结果 - Krushna C. Patra

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    The pentose phosphate pathway and cancer

    The pentose phosphate pathway and cancer 由 Krushna C. Patra, Nissim Hay

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm

    Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm 由 Krushna C. Patra, Nabeel Bardeesy, Yusuke Mizukami

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation

    Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation 由 Véronique Nogueira, Krushna C. Patra, Nissim Hay

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin

    Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin 由 Dannielle C. DeWaal, Véronique Nogueira, Alexander R. Terry, Krushna C. Patra, Sang‐Min Jeon, Grace Guzman, Jennifer Au, Christopher P. Long, Maciek R. Antoniewicz, Nissim Hay

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer

    DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer 由 Nilotpal Roy, Prashant V. Bommi, Uppoor G. Bhat, Shaumick Bhattacharjee, Indira Elangovan, Jing Li, Krushna C. Patra, Dragana Kopanja, Adam Blunier, Richard V. Benya, Srilata Bagchi, Pradip Raychaudhuri

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    <i>Kras</i> and <i>Tp53</i> Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma

    <i>Kras</i> and <i>Tp53</i> Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma 由 Margaret Hill, W. Brock Alexander, Bing Guo, Yasutaka Kato, Krushna C. Patra, Michael R. O’Dell, Matthew N. McCall, Christa L. Whitney‐Miller, Nabeel Bardeesy, Aram F. Hezel

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis

    A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis 由 Catherine Blaha, Gopalakrishnan Ramakrishnan, Sang‐Min Jeon, Véronique Nogueira, Hyunsoo Rho, Soeun Kang, Prashanth T. Bhaskar, Alexander R. Terry, Alexandre F. Aissa, Maxim V. Frolov, Krushna C. Patra, R. Brooks Robey, Nissim Hay

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

    Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer 由 Krushna C. Patra, Qi Wang, Prashanth T. Bhaskar, Luke Miller, Zebin Wang, Will Wheaton, Navdeep S. Chandel, Markku Laakso, William J. Muller, Eric L. Allen, Abhishek Jha, Gromoslaw A. Smolen, Michelle Clasquin, R. Brooks Robey, Nissim Hay

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    REDD1 loss reprograms lipid metabolism to drive progression of <i>RAS</i> mutant tumors

    REDD1 loss reprograms lipid metabolism to drive progression of <i>RAS</i> mutant tumors 由 Shuxi Qiao, Siang‐Boon Koh, Varunika Vivekanandan, Devika Salunke, Krushna C. Patra, Elma Zaganjor, Kenneth N. Ross, Yusuke Mizukami, Sarah Jeanfavre, Athena L. Chen, Mari Mino‐Kenudson, Sridhar Ramaswamy, Clary B. Clish, Marcia C. Haigis, Nabeel Bardeesy, Leif W. Ellisen

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism

    Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism 由 Krushna C. Patra, Yasutaka Kato, Yusuke Mizukami, Sebastian A. Widholz, Myriam Boukhali, Iulia Revenco, Elizabeth Grossman, Fei Ji, Ruslan I. Sadreyev, Andrew S. Liss, Robert A. Screaton, Kei Sakamoto, David P. Ryan, Mari Mino‐Kenudson, Carlos Fernández‐del Castillo, Daniel K. Nomura, Wilhelm Haas, Nabeel Bardeesy

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms

    Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms 由 Gary K.L. Chan, Samantha Maisel, Yeonjoo Hwang, Bryan C Pascual, Rebecca RB Wolber, Phuong Vu, Krushna C. Patra, Mehdi Bouhaddou, Heidi L. Kenerson, Huat Chye Lim, Donald Long, Raymond S. Yeung, Praveen Sethupathy, Danielle L. Swaney, Nevan J. Krogan, Rigney E. Turnham, Kimberly J. Riehle, John D. Scott, Nabeel Bardeesy, John D. Gordan

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Data from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

    Data from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming 由 Ilaria Gritti, Jinkai Wan, Vajira Weeresekara, Joel Markus Vaz, Giuseppe Tarantino, Tenna Holgersen Bryde, Vindhya Vijay, Ashwin V. Kammula, Prabhat Kattel, Songli Zhu, Phuong Vu, Marina Chan, Meng‐Ju Wu, John D. Gordan, Krushna C. Patra, Vanessa S. Silveira, Robert T. Manguso, Marc N. Wein, Christopher J. Ott, Jun Qi, David Liu, Kei Sakamoto, Taranjit S. Gujral, Nabeel Bardeesy

    出版 2025
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  13. 13
    TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

    TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma 由 Lipika Goyal, Lei Shi, Leah Y. Liu, Ferran Fece de la Cruz, Jochen K. Lennerz, Srivatsan Raghavan, Ignaty Leschiner, Liudmila Elagina, Giulia Siravegna, Raymond W.S. Ng, Phuong Vu, Krushna C. Patra, Supriya K. Saha, Raul N. Uppot, Ron Arellano, Stephanie Reyes, Takeshi Sagara, Sachie Otsuki, Brandon Nadres, Heather A. Shahzade, Ipsita Dey‐Guha, Isobel J. Fetter, Islam Baiev, Emily E. Van Seventer, Janet E. Murphy, Cristina R. Ferrone, Kenneth K. Tanabe, Vikram Deshpande, James J. Harding, Rona Yaeger, Robin Kate Kelley, Alberto Bardelli, A. John Iafrate, William C. Hahn, Cyril H. Benes, David T. Ting, Hiroshi Hirai, Gad Getz, Dejan Juric, Andrew X. Zhu, Ryan B. Corcoran, Nabeel Bardeesy

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: